Funded Tech Companies
ImmunGene
ImmunGene, operating out of Thousand Oaks, received equity investments from Ally Bridge Group, Johnson & Johnson Development Corporation and TL Ventures.
Company Overview
Company Name
ImmunGene
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
558 St. Charles Dr. 200
Thousand Oaks, CA 93012
USA
Thousand Oaks, CA 93012
USA
Phone
Website
Email Address
Company Background Information
Overview
ImmunGene is a drug discovery and development company, developing monoclonal antibody-based therapeutics to treat cancer and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/8/2013
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sanjay Khare
Chief Operating Officer
Raj Sachdev
Chief Scientific Officer
Michael Gresser
Chief Scientific Officer
Iqbal Grewal
VP - Bus. Development
Linda Pullan
Company Investors
- Ally Bridge Group (Frank Yu)
- Johnson & Johnson Development Corporation
- TL Ventures
- MDS Capital
- Anthem Capital
- Canaan Partners
- Flare Capital Partners
- Burrill & Company
Browse more funded tech companies:
ImmuneXcite | Immunic Therapeutics
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs